Prevention of mortality from hepatitis B and hepatitis C
- 15 September 2006
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 368 (9539) , 896-897
- https://doi.org/10.1016/s0140-6736(06)69347-1
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Treating viral hepatitis C: efficacy, side effects, and complicationsGut, 2006
- Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage studyThe Lancet, 2006
- Evolution of multi-drug resistant hepatitis B virus during sequential therapyHepatology, 2006
- A Treatment Algorithm for the Management of Chronic Hepatitis B Virus Infection in the United States: An UpdateClinical Gastroenterology and Hepatology, 2006
- Impact of hepatitis B vaccination on hepatitis B disease and nucleic acid testing in high-prevalence populationsJournal of Clinical Virology, 2006
- Natural History of Chronic Hepatitis B Virus Infection: What We Knew in 1981 and What We Know in 2005Hepatology, 2006
- Prevention and treatment of recurrent Hepatitis B after liver transplantation: the current role of nucleoside and nucleotide analoguesAnnals of Clinical Microbiology and Antimicrobials, 2006
- Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-upAnnals of Internal Medicine, 2005
- Hepatocellular carcinoma in cirrhosis: Incidence and risk factorsGastroenterology, 2004
- Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver DiseaseNew England Journal of Medicine, 2004